The DOI matches its Crossref record; 272 of the 275 references it cites were found in a registry or an index; 102 of the 220 sources its claims cite were checked for support.
Transition from inflammation to proliferation: a critical step during wound healing
Open accessAbstract
The ability to rapidly restore the integrity of a broken skin barrier is critical and is the ultimate goal of therapies for hard-to-heal-ulcers. Unfortunately effective treatments to enhance healing and reduce scarring are still lacking. A deeper understanding of the physiology of normal repair and of the pathology of delayed healing is a prerequisite for the development of more effective therapeutic interventions. Transition from the inflammatory to the proliferative phase is a key step during healing and accumulating evidence associates a compromised transition with wound healing disorders. Thus, targeting factors that impact this phase transition may offer a rationale for therapeutic development. This review summarizes mechanisms regulating the inflammation-proliferation transition at cellular and molecular levels. We propose that identification of such mechanisms will reveal promising targets for development of more effective therapies.
Overview
CoChat Summary
TL;DR
This review argues that the transition from inflammation to proliferation is a critical, therapeutically targetable step in skin wound healing, and that failed or inefficient transition underlies chronic wounds and excessive scarring. It synthesizes cellular, molecular, transcriptional, epigenetic, and miRNA regulators—especially macrophages, bioactive lipids, redox signals, TLR negative feedback, transcription factors, and miRNAs—as candidate targets.
Key findings
- Normal healing is described as four overlapping phases: haemostasis (0–several hours), inflammation (1–3 days), proliferation (4–21 days), and remodelling (21 days–1 year); inflammation usually lasts 2–5 days, neutrophils remain 2–5 days, monocytes are recruited approximately 3 days after injury, and wound-edge keratinocytes begin proliferating approximately 2–3 days after injury.
- The macrophage M1-to-M2 phenotype switch is critical for resolving inflammation and tipping the balance to tissue repair; efferocytosis of neutrophils is a central element inducing this switch, and defective M1–M2 transition is implicated in chronic wounds, including iron overload and diabetes-related impairment.
- Multiple regulators facilitate the inflammation–proliferation transition: bioactive lipid mediators (e.g., PGE2, lipoxins, resolvins, protectins, endocannabinoids, sphingolipids), redox signals (low ROS promote proliferation/angiogenesis; excessive ROS cause oxidative stress in chronic wounds), negative regulation of TLR signalling, transcription factors (GRs, ARs, ERs, PPARs, AP-1, E2F1, Smads, EGR1, Hox genes), epigenetic regulators, and miRNAs.
- Chronic wounds and scarring are associated with excessive or prolonged inflammation; up to one-third of treated chronic wound patients experience four or more recurrence episodes, healed skin reaches maximum ∼80% of original tensile strength, and mouse studies have implicated more than 100 genes in skin wound healing.
Methods
- Design: narrative review of mechanisms regulating the inflammation–proliferation transition in normal physiologic and impaired skin wound healing.
- Data or sample: literature synthesis; no primary experimental sample, with evidence drawn from human studies and animal/ex vivo models including mouse, pig, rabbit, porcine burn, and Drosophila/zebrafish.
- Main analysis: qualitative synthesis organized by cell types (e.g., macrophages, stromal cells), molecular pathways (bioactive lipids, redox, TLR signalling), transcription factors, epigenetic mechanisms, miRNAs, wound complications, and animal models.
Limitations
- Stated: for most factors discussed, their expression pattern and function in abnormal wound healing remain unknown, and investigation across wounds of different aetiologies is needed for personalized wound treatment.
- Stated: knowledge of adaptive immunity in wound healing is sparse; the exact role of epigenetic regulation in wound healing remains largely unexplored; the specific role of endocannabinoids in skin wound healing remains largely unexplored; and TLR expression/function in chronic wounds remains largely unknown.
- Evident: as a narrative review, it does not report a systematic search, quality appraisal, or meta-analysis; animal models differ from human skin (e.g., mouse wound contraction versus human re-epithelialization, and greater hair density in mouse skin), limiting translation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
81 Valid · 2 Not valid · 75 Not checked · 28 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Impairment of efferocytosis of macrophages, observed in diabetic wounds, prolongs the inflammatory phase and delays healing [70].”
§ Transition from inflammation to proliferation: a critical step during wound healing > Factors regulating the transition from inflammation to proliferation during wound healing > Macrophages
What the sources say
- Supportedcites [70] Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C, Bhasker V, Gordillo GM, Sen CK, Roy S (2010) Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One 5(3):e9539 source
The Discussion states that impaired dead-cell clearance by macrophages in diabetic wounds increases the apoptotic-cell burden, which prolongs inflammation and compromises healing. The paper's efferocytosis findings come from diabetic mouse wounds; it also reports increased apoptotic-cell burden in human diabetic wounds. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“As mentioned above, IL-4 and IL-13 are the canonical factors inducing the M2 phenotype, however, recent studies show that they are not necessary for modulating macrophage phenotypes in wounds in vivo [61, 62].”
§ Transition from inflammation to proliferation: a critical step during wound healing > Factors regulating the transition from inflammation to proliferation during wound healing > Macrophages
What the sources say
- Not checked — no full text of the sourcecites [61] Daley JM, Brancato SK, Thomay AA, Reichner JS, Albina JE (2010) The phenotype of murine wound macrophages. J Leukoc Biol 87(1):59–67 source
- Could not verifycites [62] Pinhal-Enfield G, Ramanathan M, Hasko G, Vogel SN, Salzman AL, Boons GJ, Leibovich SJ (2003) An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am J Pathol 163(2):711–721 sourceExperimental — accuracy not yet measured
The Preparation and Treatment of Peritoneal Macrophages section describes experiments on cultured mouse cells, and the Discussion relates a TLR–adenosine pathway to wound healing. Neither section establishes whether IL-4 or IL-13 is necessary for macrophage phenotype changes in wounds in vivo; searches for IL-4, IL-13, and in-vivo wound phenotypes found no passage addressing that question. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Upon injury, prostaglandins and leukotrienes are produced by infiltrating immune cells, which activate and amplify inflammation [95].”
§ Transition from inflammation to proliferation: a critical step during wound healing > Factors regulating the transition from inflammation to proliferation during wound healing > Bioactive lipid mediators
What the sources say
- Supportedcites [95] Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8(5):349–361 source
The main text says prostaglandins and leukotrienes are rapidly produced by leukocytes during acute challenge, while the Figure 1 discussion says they initiate and amplify acute inflammation. It also describes local release of these mediators from infiltrating cells during injury. Page numbers are not provided in the supplied passages. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Cytokine deprivation induces apoptosis of inflammatory cells, which often happen at the peak of the inflammatory response, triggering resolution of inflammation [91].”
§ Transition from inflammation to proliferation: a critical step during wound healing > Factors regulating the transition from inflammation to proliferation during wound healing > Stromal microenvironment
What the sources say
- Partly supportedcites [91] Orteu CH, Poulter LW, Rustin MH, Sabin CA, Salmon M, Akbar AN (1998) The role of apoptosis in the resolution of T cell-mediated cutaneous inflammation. J Immunol 161(4):1619–1629 sourceExperimental — accuracy not yet measured
The Discussion says cytokine withdrawal may cause T-cell apoptosis during resolution of the Mantoux response. It distinguishes this from apoptosis at the response peak, when IL-2 and IL-15 were high and other mechanisms were likely responsible. The supplied copy does not give a page number. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, recent studies reveal that low levels of ROS can also function as mediators of intracellular signalling, playing crucial roles throughout the healing process (reviewed in [120]).”
§ Transition from inflammation to proliferation: a critical step during wound healing > Factors regulating the transition from inflammation to proliferation during wound healing > Redox signals
What the sources say
- Supportedcites [120] Sen CK, Roy S (2008) Redox signals in wound healing. Biochim Biophys Acta 1780(11):1348–1361 source
The review describes ROS as signaling mediators in hemostasis and gives examples of low-concentration ROS activity in inflammation and re-epithelialization. Its concluding passage says that numerous aspects of wound healing are subject to redox control, while distinguishing potentially useful low ROS concentrations from harmful high levels. Page numbers are unavailable in our copy. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
101 more claims · 38 with their cited sources checked
Create a free account to see all 186 claims and to verify the 5 references still open.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 69
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Transition from inflammation to proliferation: a critical step during wound healing > Factors regulating the transition from inflammation to proliferation during wound healing > MicroRNAs
“| mir-99 family | mir-99 family | Downb | Keratinocyte | Promotes keratinocyte proliferation and migration | IGF1R, mTOR, AKT1 | [209, 230] |”
§ Transition from inflammation to proliferation: a critical step during wound healing > Factors regulating the transition from inflammation to proliferation during wound healing > MicroRNAs
“Jin et al. showed that downregulation of the miR-99 family members leads to activation of AKT/mTOR signalling pathway by targeting insulin-like growth factor 1 receptor (IGF1R), mechanistic target of rapamycin (mTOR) and V-Akt Murine Thymoma Viral Oncogene Homolog (AKT) 1, which in turn activates keratinocyte proliferation and migration, and facilitates wound closure [230].”
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 3×
“PAMPs expressed by microbes and DAMPs produced during cellular stress in synergy with natural killer cell-derived IFN-c polarize macrophages into classically activated macrophages (M1 subset), which promote Th1–Th17 immunity, host defense and antitumor immunity [49].”
BackgroundInfluentialPattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Long non-coding RNAs: insights into functions
Mercer, T. R., Dinger, M. E., & Mattick, J. S. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2521 · Cited by 5,654
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Wound Healing--Aiming for Perfect Skin Regeneration
Martin, P. (1997) · Science · doi:10.1126/science.276.5309.75 · Cited by 4,804 · cited 1×
“Thrombocytes aggregate and trigger vasoconstriction to reduce blood loss, which results in hypoxia, increased glycolysis and pH changes [7, 8].”
BackgroundTaganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Cited by
Skin Wound Healing: An Update on the Current Knowledge and Concepts
Sorg, H., Tilkorn, D. J., Hager, S., Hauser, J., & Mirastschijski, U. (2017) · European Surgical Research · doi:10.1159/000454919 · Cited by 1,263
The Neutrophil’s Role During Health and Disease
Liew, P. X., & Kubes, P. (2019) · Physiological Reviews · doi:10.1152/physrev.00012.2018 · Cited by 1,175
Conductive Biomaterials as Bioactive Wound Dressing for Wound Healing and Skin Tissue Engineering
Yu, R., Zhang, H., & Guo, B. (2022) · Nano-Micro Letters · doi:10.1007/s40820-021-00751-y · Cited by 880
Skin Acute Wound Healing: A Comprehensive Review
Cañedo-Dorantes, L., & Cañedo-Ayala, M. (2019) · International Journal of Inflammation · doi:10.1155/2019/3706315 · Cited by 691
“An ordered and well-controlled inflammatory phase is essential for the normal progress of tissue-repair and remodeling phases of wound healing [68, 85].”
BackgroundEllis, S., Lin, E. J., & Tartar, D. (2018) · Current Dermatology Reports · doi:10.1007/s13671-018-0234-9 · Cited by 625
Metadata
- Authors
- Landén, N. X., Li, D., & Ståhle, M.
- Affiliations
- Karolinska University Hospital (SE)
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2016-05-14
- Volume
- 73
- Issue
- 20
- Pages
- 3861-3885
- ISSN
- 1420-682X (ISSN-L)
- 1420-9071
- PMC
- PMC5021733
- OpenAlex
- W2353982544
- Cited by
- 1,980
- References
- 275
- Citations by year
- 2026: 276 · 2025: 360 · 2024: 328 · 2023: 234 · 2022: 237 · 2021: 188 · 2020: 161 · 2019: 97 · 2018: 69 · 2017: 24 · 2016: 5
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Cellular and Molecular Life Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet (K2014-85X-22500-01-3)
- Ragnar Söderbergs stiftelse
- Hedlunds Foundation
- Welander and Finsens Foundation
- Åke Wibergs Foundation
- Jeanssons Stiftelser
- Topics
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
- Keywords
- wound healing, delayed wound healing, skin barrier repair, scar formation, therapeutic target, cellular and molecular mechanisms
- MeSH terms
- Animals, Disease Models, Animal, Humans, Inflammation, Models, Biological, Skin, Wound Healing, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transition from inflammation to proliferation: a critical step during wound healing. https://app.cochat.ai/papers/10.1007/s00018-016-2268-0
- The paper
- Landén, N. X., Li, D., & Ståhle, M. (2016). Transition from inflammation to proliferation: a critical step during wound healing. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-016-2268-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.